| CRISPR Medicine | This is an overview of articles on delivery
Sign-up to weekly Newsletter here.
Webinar
Read more about the webinar - A Novel Non-viral Cargo Delivery Platform: The First in a New Class
Irish-Indian company CyGenica is on a mission to solve the huge challenge surrounding targeted intracellular delivery of gene-editing and other...
At a length of around 100 nucleotides, single guide RNAs are not synthesised efficiently. However, thanks to click chemistry, they can now be...
Extended survival times and inhibited growth of patient-derived glioblastoma brain tumours have been achieved in mice with CRISPR-Cas9 mediated...
A CRISPR-based therapy for the metabolic liver disease phenylketonuria (PKU) has moved one step forward. In vivo prime editing in neonate mice...
Most pharmaceuticals don't reach the brain, leaving cognitive impairments due to diseases like mucopolysaccharidoses (MPS) hard to treat. Now, a...
In a CRISPR first, scientists in Canada have used bacterial conjugation to deliver a CRISPR system to antibiotic-resistant bacteria in the mouse gut....
Chinese researchers have invented a novel system, AdBlue, to construct adenovirus vectors for CRISPR-Cas9 mediated gene editing. The novel system is...